[TARS] YoY Annual Result on 31-Dec-2022 [#FY]

Stock
[TARS] Tarsus Pharmaceuticals, Inc.
Announcement Date
16-Mar-2023
Financial Year
2022
Quarter
31-Dec-2022 [#FY]
Profit Trend
YoY- -349.06%
Quarter Report
TARS's Result
TARS's Financial Summary
View:
Show?
Annual Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
Revenue 17,447 25,816 57,027 0 0 0 -
PBT -135,893 -62,095 -13,772 -26,810 -4,669 -1,318 152.60%
Tax 0 -4 55 1 1 1 -
NP -135,893 -62,091 -13,827 -26,811 -4,670 -1,319 152.56%
Tax Rate - - - - - - -
Total Cost 153,340 87,907 70,854 26,811 4,670 1,319 158.73%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
NP Margin -778.89 -240.51 -24.25 0.00 0.00 0.00 -
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 CAGR
EPS -4.62 -2.52 -0.67 -1.32 -0.24 -0.31 71.60%
EPS Diluted -4.62 -2.52 -0.67 -1.32 -0.24 -0.31 71.60%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.